Ervaccine Technologies is Drug Discovery in France that focus on human microbiome business. Founded in 2019. They cover business area such as operator, research and development platform, therapeutic cancer vaccine, antigen, human endogenous retrovirus, herv, HERVS, ancestrally-acquire viral element, many cancer type, patient, access.
2019
( 5 years old in 2024 )
Human Microbiome
-
28 Rue Laennec
69008 Lyon
France
Private
operatorresearch and development platformtherapeutic cancer vaccineantigenhuman endogenous retrovirushervHERVSancestrally-acquire viral elementmany cancer typepatientaccess
* We use standard office opening hours in near Ervaccine Technologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ervaccine Technologies is Drug Discovery business from France that founded in 2019 (5 years old in 2024), Ervaccine Technologies business is focusing on Human Microbiome.
Ervaccine Technologies headquarter office and corporate office address is located in 28 Rue Laennec 69008 Lyon France.
Ervaccine Technologies was founded in France.
In 2024, Ervaccine Technologies is currently focus on human microbiome sector.
Above is snippet of Google Trends for "human microbiome" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ervaccine Technologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
